晨会纪要（R3） 晨会纪要 2025 年 09 月 04 日 请务必阅读正文之后的免责声明 证券研究报告 | 市场数据 | | | | --- | --- | --- | | 指数名称 | 收盘 | 涨跌% | | 上证指数 | 3813.56 | -1.16 | | 深证成指 | 12472.00 | -0.65 | | 创业板指 | 2899.37 | 0.95 | | 科创 50 | 1306.48 | -1.64 | | 北证 50 | 1551.45 | -1.49 | | 沪深 300 | 4459.83 | -0.68 | 上证指数-沪深 300 走势图 -3% 17% 37% 57% 2024-09 2024-12 2025-03 2025-06 上证指数 沪深300 | 黄红卫 | 分析师 | | --- | --- | | 执业证书编号:S0530519010001 | | | huanghongwei@hnchasing.com | | | 管诗睿 | 研究助理 | | guanshirui@hnchasing.com | | | 晨会聚焦 | | --- | 一、财信研究观点 【市场策 ...

Core Viewpoint - The company has received a medical device registration certificate for its endoscope cleaning workstation, which enhances its product offerings in the medical infection control sector [1][5]. Medical Device Registration Details - Product Name: Endoscope Cleaning Workstation [1] - Registration Number: Lu Xie Zhu Zheng 20252110546 [1] - Registered Entity: Shandong Xinhua Medical Instrument Co., Ltd. [1] - Registered Address: Xinhua Medical Technology Park, High-tech Industrial Development Zone, Zibo City, Shandong Province [1] - Production Address: No. 1 Jiuzhou Road, Baita Town, Boshan District, Zibo City, Shandong Province (Contract Manufacturing) [1] - Structure and Composition: The workstation consists of various components including ultrasonic tank, cleaning tank, rinsing tank, disinfection tank, final rinsing tank, and drying platform for soft and hard endoscopes [1][2]. Product Characteristics - The endoscope cleaning workstation features an integrated design for efficient cleaning and disinfection processes, utilizing imported PMMA polymer materials for durability and ease of cleaning [4]. - It includes an intelligent control system for multi-tank independent operation, automating standard processes such as enzyme washing and ultrasonic oscillation [4]. - The workstation ensures thorough cleaning with high-pressure flushing and features a gas dilution discharge system to eliminate harmful vapors [4]. - It meets national standards for endoscope cleaning and disinfection, with real-time monitoring and data traceability capabilities [4]. Impact on Company Performance - The introduction of the new generation endoscope cleaning workstation expands the company's technological layout in medical infection control, enhancing its core competitiveness in the disinfection field [5].

Key Points - Tianpu Co., Ltd. announced a suspension of trading for stock verification due to multiple instances of abnormal trading fluctuations from August 22 to September 3, with a reminder for investors about market risks [1] - China Shipbuilding Industry Corporation announced a share exchange ratio of 1:0.1339 for the merger with China Shipbuilding, with the stock ceasing to be listed from September 5, 2025 [2] - Chengdu Huamei reported that its 40G high-precision RF ADC chip is still in the trial production stage and has not achieved mass sales, indicating market demand uncertainty [2] - Taihe Technology's sulfide solid electrolyte project is currently in the trial production phase and has not generated sales revenue [3] - Robotech signed a contract worth approximately €946.50 million for fully automated silicon photonic packaging equipment, expected to positively impact the company's future performance [4] - Wento Holdings reported that its cinema and gaming businesses are still in the recovery phase post-restructuring, with potential uncertainties in future operations [5] - Xibu Muye's fresh milk production increased by 4.8% month-on-month in August [6] - China Shipbuilding announced the implementation of a share exchange merger with China Heavy Industry [6] - Gansu Energy plans to invest CNY 40.89 billion in a wind-solar integrated project [6] - Xinhua Medical's endoscope cleaning workstation received a Class II medical device registration certificate [6]

Investment Cooperation and Operational Status - Robotech signed a contract for fully automated silicon photonic packaging equipment worth approximately €9.465 million [1] - Qianjiang Robotics, a subsidiary of Aishida, signed a framework cooperation agreement with Honglu Steel Structure to supply 1,888 welding robots, establishing a long-term partnership [1] - Gansu Energy plans to invest in a 1 million kilowatt wind-solar integrated project in Minqin, with a total dynamic investment of CNY 4.089 billion [1] - Wantong Development will steadily advance the integration of Beijing Shudu Information Technology Co., which is currently in a loss state, as part of its transformation strategy [1] - Yongzhen Co.'s wholly-owned subsidiary received CNAS laboratory accreditation [1] - Xinhua Medical's endoscope cleaning workstation obtained Class II medical device registration [1] - Changqing Technology plans to issue convertible bonds to raise no more than CNY 800 million for the first phase of its polymer new material production base in Taizhou [1] Technological Development - Tieliu Co. signed a framework agreement with the Yangtze River Delta Hart Robot Industry Technology Research Institute, focusing on the design of key robot components and advanced control technology research [2]

Group 1 - Shengtun Mining plans to repurchase shares worth between 500 million and 600 million yuan, with a maximum repurchase price of 11.82 yuan per share, aimed at employee stock ownership plans or equity incentives [1] - Kangnbei received a drug registration certificate for Linggui Shugan Granules, which is derived from traditional Chinese medicine and is used for treating phlegm and dampness due to Yang deficiency [2] - Zhangjiang Hi-Tech intends to publicly transfer 100% equity and related debts of Shanghai Jixin Rui Construction Technology Co., Ltd. with a total price not less than 151 million yuan [3] Group 2 - Shankai Intelligent won a bid for a metering device procurement project worth 13.318 million yuan from Hohhot Water Supply Company [4] - Hason Co. plans to jointly establish a supply chain company with a registered capital of 10 million yuan, in which Hason will hold a 10% stake [5] - Pudong Construction's subsidiaries won multiple major projects with a total amount of 1.271 billion yuan [6] Group 3 - Jinling Pharmaceutical received approval for the Phase III clinical trial of Olaratogrel tablets, which are used for treating moderate to severe pain associated with endometriosis [8] - Menohua's subsidiary obtained a drug registration certificate for Mosapride Citrate Tablets, aimed at improving gastrointestinal symptoms [10] - Shapuaisi's major shareholder plans to reduce holdings by up to 2% of the company's shares due to personal financial needs [11] Group 4 - Changyuan Power reported an August electricity generation of 3.771 billion kWh, a year-on-year decrease of 6.03% [15][16] - Xibu Livestock's August fresh milk production increased by 4.8% month-on-month but decreased by 7.27% year-on-year [19] - Yong'an Pharmaceutical's actual controller and chairman had their detention lifted, allowing them to resume normal duties [20] Group 5 - Jinkai Intelligent's director resigned due to work adjustments [22] - Xinhua Medical received a Class II medical device registration for an endoscope cleaning workstation [23] - Haishi Science and Technology's innovative drug HSK47388 received approval for a new indication clinical trial [25] Group 6 - Baotai Co. plans to participate in a land use rights auction in Baoji City with a starting price of 57.34 million yuan [26] - Minfeng Special Paper received a government subsidy totaling 11.2 million yuan [27] - Jiuchang Bio obtained a medical device registration for a heparin-binding protein assay kit [29] Group 7 - Jingao Technology plans to repurchase shares worth between 200 million and 400 million yuan, with a maximum price of 17.36 yuan per share [31] - Youxunda won a bid for a metering equipment project from China Southern Power Grid worth approximately 161 million yuan [32] - Qianli Technology reported an August vehicle sales increase of 168.55% year-on-year [32] Group 8 - Guangzhou Port expects an August container throughput increase of 1.2% year-on-year [32] - Kexing Pharmaceutical's GB08 injection completed the first subject enrollment for Phase II clinical trials [33] - Wu Ming Pharmaceutical plans to transfer 98.9% of its subsidiary's shares to a newly established wholly-owned subsidiary [34] Group 9 - Shanghai Electric's acquisition of K-Electric Limited shares has not yet completed the transfer [35] - Fulai New Materials plans to raise no more than 710 million yuan through a private placement [36] - Huaren Health's drug registration application for a new type of potassium ion competitive acid blocker has been accepted [37]

Core Viewpoint - The company has received a medical device registration certificate for its endoscope cleaning workstation, which will enhance its position in the medical infection control sector [1] Group 1: Company Developments - The company announced the receipt of the registration certificate from the Shandong Provincial Drug Administration for its endoscope cleaning workstation [1] - The product is designed for the cleaning and disinfection of flexible endoscopes and the cleaning of rigid endoscopes [1] - Obtaining this registration certificate will further expand the company's technological layout in the field of medical infection control [1] Group 2: Industry Impact - The new product will strengthen the hospital infection prevention and control system [1]

Core Viewpoint - Xinhua Medical (600587.SH) has received the Medical Device Registration Certificate from the Shandong Provincial Drug Administration for its new product, the endoscope cleaning workstation, which enhances its position in the medical infection control sector [1] Group 1: Product Development - The endoscope cleaning workstation is designed for the cleaning and disinfection of both flexible and rigid endoscopes, indicating a comprehensive approach to infection control [1] - The introduction of this next-generation product expands Xinhua Medical's technological layout in the field of medical infection control [1] Group 2: Market Positioning - The intelligent cleaning and disinfection solutions provided by the new workstation strengthen the hospital infection prevention and control system [1] - This product offering provides customers with multiple options, which is beneficial for enhancing the company's medical equipment product matrix [1] - The launch of the endoscope cleaning workstation is expected to continuously consolidate the company's core competitiveness in the disinfection field [1]

Core Viewpoint - Xinhua Medical (600587.SH) has received a medical device registration certificate from the Shandong Provincial Drug Administration for its new product, the endoscope cleaning workstation, which enhances its technology layout in the field of medical infection control [1] Group 1: Product Development - The endoscope cleaning workstation is designed for cleaning and disinfecting both flexible and rigid endoscopes, indicating a comprehensive approach to infection control [1] - The introduction of this next-generation product expands Xinhua Medical's offerings in the medical equipment sector, particularly in the disinfection and cleaning domain [1] Group 2: Market Positioning - The intelligent cleaning and disinfection solutions provided by the new workstation strengthen the hospital infection prevention and control system, offering multiple options for customers [1] - This product launch is expected to enhance the company's product matrix in medical devices, thereby solidifying its core competitiveness in the cleaning and disinfection field [1]